Graph of Skin Cancer: Fwd: Interferon-alpha for recurrent World Health Organization grade 1 intracranial meningiomas.

Monday, September 15, 2008

Fwd: Interferon-alpha for recurrent World Health Organization grade 1 intracranial meningiomas.

---------- Forwarded message ----------
From: HubMed - cancer <rssfwd@rssfwd.com>
Date: Sun, Aug 31, 2008 at 7:09 AM
Subject: Interferon-alpha for recurrent World Health Organization grade 1 intracranial meningiomas.
To: mesothelioma77@gmail.com

[1]Cancer. 2008 Aug 28;
Chamberlain MC, Glantz MJ

BACKGROUND.: Intracranial meningiomas are common, they frequently recur after surgery or radiotherapy, and there are limited data regarding the treatment of intracranial meningiomas with chemotherapy. A phase 2 study was designed to estimate the 6-month progression-free survival of patients with recurrent, treatment-refractory, World Health Organization grade 1 meningiomas who were treated with interferon-alpha. METHODS.: Thirty-five patients with recurrent meningiomas ranging in age from 36 years to 88 years (median age, 61 years) were treated according to a prospective phase 2 study. All patients had received prior surgery, radiotherapy, (involved-field radiotherapy in 35 patients andstereotactic radiotherapy in 22 patients), and chemotherapy (hydroxyurea in 19 patients and other in 17 patients). On radiographic documentation of progressive disease, interferon-alpha (at a dose of 10 million U/m(2) administered subcutaneously every other day) was initiated. A complete blood count and chemistry panel was obtained before every cycle, and cranial magnetic resonance images were obtained every 3 months. RESULTS.: The most common grade 3 and 4 toxicities were fatigue (6 patients; 17%), anemia (3 patients; 8.6%), and leukopenia (3 patients; 8.6%) (toxicities were graded according to the National Cancer Institute's Common Toxicity Criteria [version 3.0]). Three patients went off study because of toxicity, and 7 patients required a dose reduction. There were no treatment-related deaths or delays in therapy reported. All patients were assessable for response. No patient demonstrated a neuroradiographic complete or partial response. Twenty-six patients demonstrated stable disease after the first 3 cycles of interferon-alpha, and 9 patients had progressive disease. The progression-free survival rate was 54% at 6 months and 31% at 12 months. The median time to tumor progression was 7 months (range, 2-24 months). The median survival was 8 months (range, 3-28 months). CONCLUSIONS.: Treatment with interferon-alpha for recurrent meningiomas was found to be tolerated moderately well and was modestly effective. Cancer 2008. (c) 2008 American Cancer Society.

___
Source: http://www.hubmed.org/display.cgi?uids=18756531
--
Powered by [5]RssFwd, a service of [6]Blue Sky Factory, Inc

Freshen Up Your Day. Watch and Upload Some Of Your Humor And Funny Stuffs, Funny Videos At aseanface.com.

You will definitely enjoy and have fun with the humor and funny stuffs that aseanFace.com has to offer. You can also join the many who have signed up and uploaded their photos and pictures, upload their favourite videos, post on forums and post bulletins, post on their Blogs. Many posts on the Blogs are Humorous and funny Stuffs.

More Links and Info Sites For Your Searches

Search Info Source

Humor and Funny Stuffs

Funny Tagalog Quotes, Funny Short Skits, Funny Car Commercials

I Need Some Funny Jokes Riddles For Teenagers, Really Funny Quick Jokes

Funny Goodbye Letters, Funny Rude Free Ecards, Funny Sick Twisted Humor

Funny Videos and Entertainment

Funny Videos